Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
Pseudoprogression of Non-Small Cell Lung Cancer Following Neoadjuvant Therapy: A Case Report
Kareem Ramadan1, Mona Benaissa2, Michael Shackcloth1
1Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, GBR.
Neoadjuvant chemoimmunotherapy for early-stage non-small cell lung cancer (NSCLC) can cause radiological progression, mimicking tumor growth. Recognizing pseudoprogression is crucial, as it may allow patients to still receive potentially curative surgery.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Imaging
Background:
- Neoadjuvant chemoimmunotherapy is a growing treatment for early-stage non-small cell lung cancer (NSCLC), improving pathological response rates.
- Radiological progression after neoadjuvant therapy can lead to withholding potentially curative surgery.
- Distinguishing true progression from pseudoprogression is critical in NSCLC management.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019